thalidomide has been researched along with angiogenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Giles, FJ; Kantarjian, H; Keating, M; O'Brien, S; Thomas, DA | 1 |
| Hisamori, S; Kadokawa, Y; Kubo, H; Mishima, M; Nakano, T; Tabata, C; Tabata, R; Takahashi, M | 1 |
| Guo, L; Liu, H; Liu, L; Ren, L; Song, N; Wan, Z; Xu, B | 1 |
3 other study(ies) available for thalidomide and angiogenin
| Article | Year |
|---|---|
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Biomarkers; Fibroblast Growth Factor 2; Hepatocyte Growth Factor; Humans; Leukemia, Myeloid; Middle Aged; Recurrence; Ribonuclease, Pancreatic; Thalidomide; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2003 |
Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
Topics: Animals; Bleomycin; Cell Differentiation; Cell Line; Cell Line, Transformed; Collagen Type I; Collagen Type I, alpha 1 Chain; Female; Fibroblasts; Humans; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Proteins; Pulmonary Fibrosis; Ribonuclease, Pancreatic; RNA, Messenger; Thalidomide; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2007 |
Blockade of angiogenin by thalidomide inhibits the tumorigenesis of murine hemangioendothelioma.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Movement; Hemangioendothelioma; Humans; Mice; Ribonuclease, Pancreatic; Thalidomide | 2019 |